摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

6-Hydroxyskimmin | 531-58-8

中文名称
——
中文别名
——
英文名称
6-Hydroxyskimmin
英文别名
6-hydroxy-7-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxychromen-2-one
6-Hydroxyskimmin化学式
CAS
531-58-8
化学式
C15H16O9
mdl
——
分子量
340.28
InChiKey
WNBCMONIPIJTSB-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    213-215° (after drying in desiccator)
  • 比旋光度:
    D18 -105° (c = 3 in 50% dioxane)
  • 沸点:
    697.7±55.0 °C(Predicted)
  • 密度:
    1.679±0.06 g/cm3(Predicted)
  • LogP:
    -2.450 (est)
  • 物理描述:
    Solid

计算性质

  • 辛醇/水分配系数(LogP):
    -0.6
  • 重原子数:
    24
  • 可旋转键数:
    3
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.4
  • 拓扑面积:
    146
  • 氢给体数:
    5
  • 氢受体数:
    9

安全信息

  • WGK Germany:
    3
  • 储存条件:
    2-8°C,存放在干燥、密封的环境中。

SDS

SDS:914d81a765b32ffa38ac1e91a13b9c75
查看

制备方法与用途

菊苣素是一种具有抗SARS-CoV-2活性的化合物,可能成为治疗重症新冠肺炎的潜在候选药物。

文献信息

  • METHODS FOR DIRECTING DIFFERENTIATION OF CLONOGENIC NEURAL STEM CELLS WITH COUMARINS
    申请人:HE Cheng
    公开号:US20090170930A1
    公开(公告)日:2009-07-02
    A method for promoting differentiation of clonogenic neural stem cells (NSCs), comprising administering to a patient in the need of such promoting a coumarin compound represented by formula I or by formula II. The representative coumarin compounds include 7-hydroxycoumarin, daphnoretin, scopoletin, edgeworin, aesculetin and esculetin-6-β-D-glucopyranoside. The coumarin compounds showed significant activity of directing the differentiation of NSCs in pharmacological test and thereof could be used to prepare drugs to direct NSCs differentiated to oligodendrocyte progenitor cells (OPCs) for the treatment of demyelinating diseases or spinal cord injury. The drug could be a pure coumarin compound or a pharmaceutical composition comprising a therapeutical dose of a coumarin compound as active ingredients and a pharmaceutically-acceptable carrier. The content of the active ingredients in the pharmaceutical composition is between 0.1% and 99.5% by weight.
查看更多